A previous study showed that intranasal OXT significantly increased plasma OXT concentrations within 40 min [69]; thus, we supposed that intranasal oxytocin—a method already proven safe and used for many years [70,71]—could probably be used to modulate cardiovascular disease in patients with insomnia. Here, OXT is linked to insomnia measurement.